Biochip for K-ras mutation screening in ovarian cancer

Clinical Chemistry

Volumn 51, Issue 4, 2005, Pages 784-787

  Fabjani, Gerhild ^a,b   Kriegshaeuser, Gernot ^c   Schuetz, Andreas ^d   Prix, Lothar ^d   Zeillinger, Robert ^a,e  

^a UNIVERSITY OF VIENNA   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c VIENNALAB DIAGNOSTICS GMBH   (Austria)

^d Biofocus GmbH   (Germany)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; ASSAY; AUTOANALYZER; CANCER PATIENT; CANCER TISSUE; CODON; COMPUTER ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA EXTRACTION; DNA ISOLATION; EVALUATION; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC SCREENING; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYBRIDIZATION; HYPOTHESIS; MUTATIONAL ANALYSIS; ONCOGENE K RAS; OVARY CANCER; OVARY CARCINOMA; OVARY TUMOR; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; ROOM TEMPERATURE; SEQUENCE ANALYSIS; STORAGE TEMPERATURE; TUMOR; UNIVERSITY; WILD TYPE;

FEMALE; GENES, RAS; HUMANS; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS;

EID: 16244398711     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.041194     Document Type: Article

References (20)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999;49:8-31.
2. Aunoble B, Sanches R, Didier E, Bignon YJ. Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer [Review]. Int J Oncol 2000;16:567-76.
3. Bos JL. ras oncogenes in human cancer: a review. Cancer Res 1989;49:4682-9.
4. Enomoto T, Weghorst CM, Inoue M, Tanizawa O, Rice JM. K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary. Am J Pathol 1991;139:777-85.
5. Teneriello MG, Ebina M, Linnoila RI, Henry M, Nash JD, Park RC, et al. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Cancer Res 1993;53:3103-8.
6. Ichikawa Y, Nishida M, Suzuki H, Yoshida S, Tsunoda H, Kubo T, et al. Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors. Cancer Res 1994;54:33-5.
7. Pieretti M, Cavalieri C, Conway PS, Gallion HH, Powell DE, Turker MS. Genetic alterations distinguish different types of ovarian tumors. Int J Cancer 1995;64:434-40.
8. Fujita M, Enomoto T, Inoue M, Tanizawa O, Ozaki M, Rice JM, et al. Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary. Jpn J Cancer Res 1994;85:1247-56.
9. Taylor RR, Linnoila RI, Gerardts J, Teneriello MG, Nash JD, Park RC, et al. Abnormal expression of the retinoblastoma gene in ovarian neoplasms and correlation to p53 and K-ras mutations. Gynecol Oncol 1995:58:307-11.
10. Haas CJ, Diebold J, Hirschmann A, Rohrbach H, Lohrs U. In serous ovarian neoplasms the frequency of Ki-ras mutations correlates with their malignant potential. Virchows Arch 1999;434:117-20.
11. Mok SC, Bell DA, Knapp RC, Fishbaugh PM, Welch WR, Muto MG, et al. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res 1993;53:1489-92.
12. Prix L, Uciechowski P, Bockmann B, Giesing M, Schuetz AJ. Diagnostic biochip array for fast and sensitive detection of K-ras mutations in stool. Clin Chem 2002;48:428-35.
13. Chien CH, Chow SN. Point mutation of the ras oncogene in human ovarian cancer. DNA Cell Biol 1993;12:623-7.
14. Fukumoto M, Estensen RD, Sha L, Oakley GJ, Twiggs LB, Adcock LL, et al. Association of Ki-ras with amplified DNA sequences, detected in human ovarian carcinomas by a modified in-gel renaturation assay. Cancer Res 1989;49:1693-7.
15. Garrett AP, Lee KR, Colitti CR, Muto MG. Berkowitz RS, Mok SC. K-ras mutation may be an early event in mucinous ovarian tumorigenesis. Int J Gynecol Pathol 2001;20:244-51.
16. Hogdall EV, Hogdall CK, Blaakaer J, Christensen L, Bock JE, Vuust J, et al. K-ras alterations in Danish ovarian tumour patients. From the Danish "Malova" Ovarian Cancer study. Gynecol Oncol 2003;89:31-6.
17. Cuatrecasas M, Villanueva A, Matias-Guiu X, Prat J. K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases. Cancer 1997;79:1581-6.
18. Varras MN, Sourvinos G, Diakomanolis E, Koumantakis E, Flouris GA, Lekka-Katsouli J, et al. Detection and clinical correlations of ras gene mutations in human ovarian tumors. Oncology 1999;56:89-96.
19. Thiede C, Bayerdorffer E, Blasczyk R, Wittig B, Neubauer A. Simple and sensitive detection of mutations in the ras proto-oncogenes using PNA-mediated PCR clamping. Nucleic Acids Res 1996;24:983-4.
20. Cuatrecasas M, Erill N, Musulen E, Costa I, Matias-Guiu X, Prat J. K-ras mutations in nonmucinous ovarian epithelial tumors: a molecular analysis and clinicopathologic study of 144 patients. Cancer 1998;82:1088-95.